Apheros Secures $1.85M

To cool down data centers, using high performance cooling systems

Apheros Notes: Data centers are the backbone of the digital age, with unprecedented demand for digital infrastructure driven by the surge in the use of AI, machine learning, and supercomputing. However, their energy consumption is skyrocketing.

By 2030, an estimated six percent of global energy consumption will be used specifically for cooling data centers. A shift from traditional cooling methods to more cost- and energy efficient liquid-based solutions is inevitable. Enabling this transition, deep tech startup Apheros is today announcing a $1.85m funding round seizing this critical moment to introduce its innovative metal foam technology, offering a superior solution to this pressing industry challenge.

The pre-seed funding round, led by venture capital firm Founderful, will accelerate development and deployment of Apheros’ revolutionary metal foam-based cooling solutions.

The Apheros patented manufacturing process creates unique foam structures with completely open porosity and unparalleled surface area, surpassing traditional solutions by a factor of thousand, which translates into exceptional heat transfer and flow properties. Ideal for high performance cooling applications, Apheros’ metal foams are easily integrated within its customers’ existing cooling systems. They address customers’ urgent needs of reduced energy consumption and cooling costs.

Apheros AG, founded in August 2023, was developed as an ETH Zurich spin-off to tackle cooling challenges in a wide range of applications including high-performance computing and mobile devices. Apheros is led by a team with a proven track record in innovation, business development and tech transfer. Apheros’ co-founder and CEO Julia Carpenter was recently named one of Switzerland’s Top 10 “Founders to Watch” for her invention of Apheros novel metal foam manufacturing process. Co-founder and CTO Gaëlle Andreatta, has over 16 years of experience in R&D, Tech Transfer, and start-up development.

Julia Carpenter, co-founder and CEO of Apheros commented: “Our technology has the potential to set new industry standards and significantly reduce the environmental impact of cooling solutions worldwide. This funding round will allow us to advance our mission of helping our customers achieve superior thermal performance, increase energy efficiency, and contribute to a greener future. Immediately, we will expand production, increase research and development efforts, and bring state-of-the-art solutions to a broader market.”

Apheros currently targets the thermal management market with a focus on liquid cooling, a segment expanding at a fast pace due to the needs created by the growing demand for High Performance Computing, Artificial Intelligence and Data Centers. More efficient cooling systems are needed to overcome current energy shortages and to reach ambitious climate protection goals. There is a pressing need to introduce higher performing cooling solutions to the market.

Gaëlle Andreatta, co-founder and CTO of Apheros added: “There is a dire need for more efficient cooling solutions. AI development is driving exponential growth in data center energy consumption and inefficient cooling is the main culprit. Our unique metal foams have superior heat exchange and fluid transport properties, especially for liquid and two-phase cooling. With our customers, we are redefining thermal management. ”

Apheros’ vision is to catalyze the transition to a more sustainable future through materials innovation. Apheros will redefine sustainable, high-performance liquid cooling and establish its products as the gold standard for sustainable, high-performance liquid cooling.

Lukas Weder, founding partner at Founderful commented: “We are excited to support Apheros’ mission to revolutionize cooling technology. Apheros’ groundbreaking approach has the potential to significantly reduce energy consumption and set new industry standards. We are confident in the team’s vision and capabilities and look forward to seeing the positive impact they will make on both the industry and the environment “

SourceApheros

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.